Cardiac Science announces definitive agreement to sell its Diagnostic Cardiology product line to Mortara Instrument, Inc.

    Cardiac Science announces definitive agreement to sell its Diagnostic
             Cardiology product line to Mortara Instrument, Inc.

PR Newswire

MILWAUKEE, Wis. and BANGALORE, India, April 1, 2013

MILWAUKEE, Wis. and BANGALORE, India, April 1, 2013 /PRNewswire/ --Cardiac
Science, an Opto Circuits group company, announced today a definitive
agreement signed on 29^th March 2013 to sell its Diagnostic Cardiology product
line to Mortara Instrument, Inc. The business consists of the well-known
Burdick and Quinton brands and associated products. The transaction does not
include MySense^®, the novel, wearable, single-patient ECG Recorder System and
the Resuscitation business unit, which markets automated external
defibrillators (AEDs) worldwide.

The boards of directors of both companies have approved the transaction. The
companies are currently operating under a transition services agreement
whereby Cardiac Science continues to support the business as a full transition
plan is implemented. Cardiac Science customers will continue to receive
technical, sales and customer service through the existing channels until they
are notified otherwise.

"Divestiture of the Diagnostic Cardiology product line will bring more
strategic focus to Cardiac Science. The company will now be able to
exclusively focus on innovation and the expansion of market share in its high
margin Resuscitation Business, " said Neal Long, CEO, Cardiac Science.

"The addition of these businesses to our organization represents a marked
opportunity to accelerate the introduction of Mortara's leading ECG technology
to new markets," commented Dr. Justin Mortara, CEO. "As a historic technology
supplier to both Burdick and Quinton, we hold an enormous amount of respect
for the people and the products behind these established names. We look
forward to marrying our ECG expertise with these powerful brands and the
know-how behind them to create exciting new solutions for our customers."

For more than three decades, Mortara has proudly served the non-invasive
diagnostic cardiology market with innovative product solutions in the areas of
Resting ECG, Holter, Cardiac Stress Testing and Patient Monitoring. "The
inclusion of these two world-class brands into the Mortara portfolio will
result in an unsurpassed choice in products and services for our global client
base. With this strategic move, Mortara expands its reach into office-based
physician practices, clinics, as well as increases its growing presence in the
acute care hospital market," said Mortara.

About Quinton and Burdick

For more than 100 years, Burdick and Quinton have established themselves as
leaders in diagnostic cardiology. Quinton's cardiac stress exercise and
rehabilitation products are widely recognized as best-in-class, while the name
Burdick is synonymous with ECG in primary care.

About Mortara Instrument

Mortara Instrument, Inc. was founded 30 years ago and today is a recognized
technology leader in the world of ECG. Mortara's global headquarters is
located in Milwaukee, Wisconsin with operations in Australia, Germany, Italy,
the Netherlands, and the United Kingdom. Mortara is distinguished in the field
of non-invasive cardiology for innovations that are the core of the company's
complete line of ECG products including electrocardiographs, stress exercise
systems, Holter systems, data warehousing solutions, and cardiology monitoring
systems. The company manufactures and distributes its ECG devices and related
technologies worldwide. Mortara's market leadership is a result of its
substantial investment in R & D which has fueled the introduction of many new
Mortara products uniquely positioned to benefit customers in their everyday
use of diagnostic ECG devices. To learn more about Mortara Instrument and its
expanding product portfolio visit www.mortara.com.

About Cardiac Science

Prior to this acquisition, Cardiac Science developed, manufactured, and
marketed a family of advanced diagnostic and therapeutic cardiology devices
and systems, including automated external defibrillators (AED),
electrocardiograph devices (ECG/EKG), cardiac stress treadmills and systems,
diagnostic workstations, Holter monitoring systems, hospital defibrillators,
vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology
data management systems (informatics) that connect with hospital information
(HIS), electronic medical record (EMR), and other information systems. The
company sells a variety of related products and consumables and provides a
portfolio of training, maintenance, and support services. Cardiac Science is
headquartered in Waukesha, Wisconsin. With customers in more than 100
countries worldwide, the company has operations in North America, Europe, and
Asia. For information, visit http://www.cardiacscience.com.

About Opto Circuits

Opto Circuits (India) Ltd. (OCI) is a vertically integrated multinational
medical technology Group that specializes in primary, acute and critical care
products for the global markets. Group companies such as Criticare, Eurocor,
Mediaid, AMDL and Unetixs Vascular are leaders in cardiac and vital signs
monitors, emergency cardiac care equipment, vascular treatments and sensing
technologies. Our USFDA listed and CE marked products are marketed in more
than 150 countries and sold through direct and indirect sales channels across
many emerging and developing economies.

We've been ranked in Forbes' Asia's 200 Best under a Billion lists in 2008,
2009 and 2011. For more information, please visit www.optoindia.com.

Media Contacts
Mortara Instrument: Sondra Kaufman; sondra.kaufman@mortara.com
Cardiac Science: Nancy Sandy; nsandy@cardiacscience.com; 608-332-6320
Opto Circuits: Anna Beck; media@optoindia.com; 80-2852-8088

SOURCE Cardiac Science

Website: http://www.cardiacscience.com